Upgrade to SI Premium - Free Trial

Stifel Reiterates Buy Rating on Abbott Labs (ABT)

July 18, 2024 8:50 AM
Stifel analyst Rick Wise reiterated a Buy rating and $115.00 price target on Abbott Labs (NYSE: ABT).The analyst comments "Delivering ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles